Tobii Validated for Windows Hello Login, Announces Support

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Dec 16, 2015 at 11:15 AM

Tobii Validated for Windows Hello Login, Announces Support for Facial Recognition

STOCKHOLM & REDMOND, WA — December 16, 2015 — Tobii (http://www.tobii.com/), the global leader in eye-tracking, in collaboration with Microsoft Corp., today announced that Tobii’s eye-tracking platforms support facial recognition for Windows Hello (http://www.tobii.com/xperience/hello/), providing consumers with simpler, faster and more secure logins. Tobii’s devices are the only eye -tracking platforms that support Windows Hello, empowering device manufacturers with both Windows 10-ready biometric authentication and eye-tracking functionality for notebooks, Ultrabooks, desktops, and peripherals, all on the same sensor. The Windows Hello biometric functionality relies on images provided by Tobii’s sensor to work with Microsoft face recognition algorithms. Built into Windows 10, these algorithms determine the identity of the user, making it possible to securely login to Windows devices. Tobii’s technology makes it possible for Windows Hello to work in a variety of lighting conditions and even in the dark. Available now for peripheral eye trackers on the Tobii IS3 platform, including Tobii EyeX and SteelSeries Sentry devices, facial recognition support for Windows Hello is intended to be standard on all future Tobii eye tracking platforms, including the recently announced Tobii IS4 platform with Tobii EyeChip™ (http://www.tobii.com/group/news-media/press-releases/tobii-unveils -next-generation-eye-tracking-platform-targeting-consumer-devices/). Tobii’s Windows Hello support illustrates yet another way in which device manufacturers can expect to deliver enhanced consumer experiences with Tobii’s technology. When you sit in front of your PC you’re automatically logged in, just by being there. Tobii’s platforms now provide even greater value on a single sensor by delivering both facial recognition and exciting new user experiences with eye-tracking. “Technology has a fundamental duty to understand humans better and improve their daily lives. With Windows Hello, a person never needs to remember their password to log in,” said Oscar Werner, president of Tobii Tech. “Microsoft’s interest to make Windows Hello work with Tobii eye-tracking devices is a testament to the value, both now and in the future, of our joint ability to enhance the Windows experience for consumers.” For those interested in exploring the next generation of simple, password-free logins today, Tobii’s Windows Hello support can be introduced to existing Windows 10 compatible PCs with the addition of the Tobii EyeX Controller (http://www.tobii.com/xperience/products/). Tobii’s Windows Hello support was developed by Tobii Tech, a business unit of Tobii. Additional Information · Device manufacturers interested in delivering world-class experiences to consumers using Tobii eye-tracking platforms, please register for the Tobii Early Access Program (http://www.tobii.com/OEM). · Developers interested building the next generation of biometric security and faster, more convenient access to apps and online services through Windows Hello, get Tobii EyeX here. (http://www.tobii.com/buy-eyex) · More information and instructions on how to enable Windows Hello for Tobii EyeX controller and SteelSeries Sentry (http://www.tobii.com/xperience/hello/) Tobii discloses this information pursuant to the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication on December 16, 2015, at 5:00 p.m. CET. Contacts Stephan Floyd, Marketing Manager, Tobii Tech, +1-781-223-2005, email: stephan.floyd@tobii.com Sara Hyléen, Corporate Communications Director, Tobii AB, +46 70 9161641, email: sara.hyleen@tobii.com About Tobii Tobii is the global leader in eye-tracking. Our vision is a world where all technology works in harmony with natural human behavior. Tobii operates through three business units: Tobii Dynavox makes specially designed computers that are controlled by eye movement or touch screens for use by people with special needs due to spinal cord injuries, CP, ALS or other medical conditions. Tobii Pro develops and sells eye-tracking equipment and services used today by more than 2,000 companies and 1,500 research institutions, including all of the world’s 50 highest ranked universities. Tobii Tech further develops Tobii’s technology for new volume markets such as computer games, personal computers, virtual reality and vehicles. Tobii is headquartered in Sweden and is listed on Nasdaq Stockholm (TOBII). The group has approximately 600 employees. For more information, please visit www.tobii.com.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

LG's ASIL D Certification: A Game Changer in Autos

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Webull Faces Class Action Suit: Key Deadlines Loom

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

D-Wave's Legal Trouble: Securities Fraud Suit Looms

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...